Regulatory News
Cell Therapy Catapult & Roslin Cells to create clinical grade stem cells to accelerate research into new treatmentsTSB releases Catapult Programme Progress Update 2012-2013Cell Therapy Catapult now eligible as partner in Biomedical Catalyst projectsCell Therapy Catapult’s innovative new facilities on track for Q1 2014 openingResponse to Regenerative Medicine report from House of Lords Science and Technology CommitteeCell Therapy and Regenerative Medicine Centres in Canada and UK Collaborating to Accelerate Commercialization of New Medicines for PatientsCell Therapy Catapult Recruits Prof Johan Hyllner as Chief Scientific OfficerCell Therapy Catapult and the UK Stem Cell Foundation Agree to CollaborateReNeuron and Cell Therapy Catapult in landmark collaboration on new cell manufacturing technologiesUK clinical trials database first major output for Cell Therapy CatapultThe Cell Therapy Catapult Announces Three Hires to its Management TeamDr John Brown appointed Chairman of Cell Therapy Catapult